Endostar First-line Treatment of Advanced NSCLC

NCT03123445 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Endostar
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

China Medical University, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]